Who invested in Glaukos?
Glaukos's investors include Versant Ventures, Domain Associates, Frazier Healthcare Partners, OrbiMed and Montreux Growth Partners, and 3 more on record.
United States · Series F startup
7 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$121Mraised across 7 rounds since 2002, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by pevc.dowjones.comSEC filing: $30M sold, first sale Jan 2013
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Oct 2012
No investor was named in the report.
Reported by sec.govSEC filing: $4.5M sold, first sale Aug 2012
Reported by fis.dowjones.comSEC filing: $30M sold, first sale Jan 2011
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Sept 2010
Reported by equityhelpdesk.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Glaukos's investors include Versant Ventures, Domain Associates, Frazier Healthcare Partners, OrbiMed and Montreux Growth Partners, and 3 more on record.
Glaukos has raised $121M across 7 rounds since 2002.
Glaukos's most recent round was a Series F of $30M in Feb 2013.
Glaukos's largest round on record is $35M (Series D), in Aug 2008.
Glaukos's first round on record, in Sept 2002, was backed by Versant Ventures, Domain Associates and Frazier Healthcare Partners.
Glaukos's latest named round is a Series F, in Feb 2013.
Glaukos is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.